Circulation Research, Vol 74, 596-603, Copyright © 1994 by American Heart Association

ARTICLES

Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle

K Tobise, Y Ishikawa, SR Holmer, MJ Im, JB Newell, H Yoshie, M Fujita, EE Susannie and CJ Homcy
Department of Medicine I, Asahikawa Medical College, Japan.

We investigated the developmental regulation of the beta-adrenergic receptor-Gs-adenylyl cyclase pathway in myocardial membranes from fetal, neonatal, adult, and mature adult rats by measuring the density of the beta-adrenergic receptor and the activities of the stimulatory guanine nucleotide-binding protein Gs and the adenylyl cyclase enzyme. Total beta-adrenergic receptor content (in femtomoles per milligram protein) was greatest in the fetal (124.4 +/- 20.5 fmol/mg) and neonatal (122.3 +/- 16.1 fmol/mg) stages and gradually decreased in the adult (90.9 +/- 8.0 fmol/mg) and mature adult (70.0 +/- 9.6 fmol/mg) stages. An equivalent pattern was seen for adenylyl cyclase activity: the basal activity of the effector enzyme or that measured in the presence of 0.1 mmol/L isoproterenol with 0.1 mmol/L Gpp(NH)p, 10 mmol/L NaF, or 0.05 mmol/L forskolin was greater in the fetus and the neonate than in the adult and the mature adult. These data suggested that decreased stimulation of the catalytic unit by Gs could be the underlying cause of diminished adenylyl cyclase activity with aging. However, quantification of Gs by reconstitution into S49 cyc- membranes (in picomoles cAMP per microgram for 10 minutes) demonstrated no significant decrease during development from fetus (1.55 +/- 0.1 pmol/microgram) to neonate (1.9 +/- 0.5 pmol/microgram) and subsequent aging to adult (2.6 +/- 0.2 pmol/micrograms) and mature adult (1.9 +/- 0.2 pmol/microgram). When Northern blot analysis was used to characterize the relative amounts of mRNA coding for Gs alpha, no significant differences were seen among the developmental stages studied.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				C.-L. Hu, R. Chandra, H. Ge, J. Pain, L. Yan, G. Babu, C. Depre, K. Iwatsubo, Y. Ishikawa, J. Sadoshima, et al. Adenylyl cyclase type 5 protein expression during cardiac development and stress Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1776 - H1782. [Abstract] [Full Text] [PDF]

				A. Younes, A. E. Lyashkov, D. Graham, A. Sheydina, M. V. Volkova, M. Mitsak, T. M. Vinogradova, Y. O. Lukyanenko, Y. Li, A. M. Ruknudin, et al. Ca2+-stimulated Basal Adenylyl Cyclase Activity Localization in Membrane Lipid Microdomains of Cardiac Sinoatrial Nodal Pacemaker Cells J. Biol. Chem., May 23, 2008; 283(21): 14461 - 14468. [Abstract] [Full Text] [PDF]

				T. Tang, M. H. Gao, N. C. Lai, A. L. Firth, T. Takahashi, T. Guo, J. X.-J. Yuan, D. M. Roth, and H. K. Hammond Adenylyl Cyclase Type 6 Deletion Decreases Left Ventricular Function via Impaired Calcium Handling Circulation, January 1, 2008; 117(1): 61 - 69. [Abstract] [Full Text] [PDF]

				C. Ulucan, X. Wang, E. Baljinnyam, Y. Bai, S. Okumura, M. Sato, S. Minamisawa, S. Hirotani, and Y. Ishikawa Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1662 - H1672. [Abstract] [Full Text] [PDF]

				J. G. Dobson Jr., L. G. Shea, and R. A. Fenton {beta}-Adrenergic and antiadrenergic modulation of cardiac adenylyl cyclase is influenced by phosphorylation Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1471 - H1478. [Abstract] [Full Text] [PDF]

				S. Okumura, J.-i. Kawabe, A. Yatani, G. Takagi, M.-C. Lee, C. Hong, J. Liu, I. Takagi, J. Sadoshima, D. E. Vatner, et al. Type 5 Adenylyl Cyclase Disruption Alters Not Only Sympathetic But Also Parasympathetic and Calcium-Mediated Cardiac Regulation Circ. Res., August 22, 2003; 93(4): 364 - 371. [Abstract] [Full Text] [PDF]

				S. Okumura, G. Takagi, J.-i. Kawabe, G. Yang, M.-C. Lee, C. Hong, J. Liu, D. E. Vatner, J. Sadoshima, S. F. Vatner, et al. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload PNAS, August 19, 2003; 100(17): 9986 - 9990. [Abstract] [Full Text] [PDF]

				A. M. Feldman Adenylyl Cyclase: A New Target for Heart Failure Therapeutics Circulation, April 23, 2002; 105(16): 1876 - 1878. [Full Text] [PDF]

				W. E. Schutzer, H. Xue, J. F. Reed, J.-B. Roullet, S. Anderson, and S. L. Mader Angiotensin II enhances beta -adrenergic receptor-mediated vasorelaxation in aortas from young but not old rats Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2807 - H2814. [Abstract] [Full Text] [PDF]

				N. Defer, M. Best-Belpomme, and J. Hanoune Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase Am J Physiol Renal Physiol, September 1, 2000; 279(3): F400 - F416. [Abstract] [Full Text] [PDF]

				L. Lipskaia, N. Defer, G. Esposito, I. Hajar, M.-C. Garel, H. A. Rockman, and J. Hanoune Enhanced Cardiac Function in Transgenic Mice Expressing a Ca2+-Stimulated Adenylyl Cyclase Circ. Res., April 14, 2000; 86(7): 795 - 801. [Abstract] [Full Text] [PDF]

				S. F. Steinberg The Molecular Basis for Distinct {beta}-Adrenergic Receptor Subtype Actions in Cardiomyocytes Circ. Res., November 26, 1999; 85(11): 1101 - 1111. [Full Text] [PDF]

				I. Espinasse, V. Iourgenko, C. Richer, M. Heimburger, N. Defer, M.-C. Bourin, F. Samson, E. Pussard, J.-F. Giudicelli, J.-B. Michel, et al. Decreased type VI adenylyl cyclase mRNA concentration and Mg2+-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn2+-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure Cardiovasc Res, April 1, 1999; 42(1): 87 - 98. [Abstract] [Full Text] [PDF]

				Y. Suzuki, T. Shen, M. Poyard, M. Best-Belpomme, J. Hanoune, and N. Defer Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1674 - C1685. [Abstract] [Full Text] [PDF]

				D. A. Roth, C. D. White, D. A. Podolin, and R. S. Mazzeo Alterations in myocardial signal transduction due to aging and chronic dynamic exercise J Appl Physiol, January 1, 1998; 84(1): 177 - 184. [Abstract] [Full Text] [PDF]

				T. Shen, Y. Suzuki, M. Poyard, M. Best-Belpomme, N. Defer, and J. Hanoune Localization and Differential Expression of Adenylyl Cyclase Messenger Ribonucleic Acids in Rat Adrenal Gland Determined by in Situ Hybridization Endocrinology, November 1, 1997; 138(11): 4591 - 4598. [Abstract] [Full Text] [PDF]

				Y. Ishikawa and C. J. Homcy The Adenylyl Cyclases as Integrators of Transmembrane Signal Transduction Circ. Res., March 1, 1997; 80(3): 297 - 304. [Full Text]

				S. F. Steinberg, H. Zhang, E. Pak, G. Pagnotta, and P. A. Boyden Characteristics of the ß-Adrenergic Receptor Complex in the Epicardial Border Zone of the 5-Day Infarcted Canine Heart Circulation, June 1, 1995; 91(11): 2824 - 2833. [Abstract] [Full Text]

				G. Iwami, J.-i. Kawabe, T. Ebina, P. J. Cannon, C. J. Homcy, and Y. Ishikawa Regulation of Adenylyl Cyclase by Protein Kinase A J. Biol. Chem., May 26, 1995; 270(21): 12481 - 12484. [Abstract] [Full Text] [PDF]